70 related articles for article (PubMed ID: 19686419)
1. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population.
Li CS; Zhang Q; Lee KJ; Cho SW; Lee KM; Hahm KB; Choi SC; Yun KJ; Chung HT; Chae SC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1692-6. PubMed ID: 19686419
[TBL] [Abstract][Full Text] [Related]
2. Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility.
Magyari L; Kovesdi E; Sarlos P; Javorhazy A; Sumegi K; Melegh B
World J Gastroenterol; 2014 Mar; 20(12):3208-22. PubMed ID: 24695754
[TBL] [Abstract][Full Text] [Related]
3. Increased synthesis and intestinal expression of IL-39 in patients with inflammatory bowel disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Barreto-Zúñiga R; Martínez-Benítez B; Yamamoto-Furusho JK
Immunol Res; 2024 Apr; 72(2):284-292. PubMed ID: 37968544
[TBL] [Abstract][Full Text] [Related]
4. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins.
Diegelmann J; Olszak T; Göke B; Blumberg RS; Brand S
J Biol Chem; 2012 Jan; 287(1):286-298. PubMed ID: 22069308
[TBL] [Abstract][Full Text] [Related]
5. Association of IL-27 gene three polymorphisms with Crohn's disease susceptibility in a Chinese Han population.
Wang Z; Wang L; Fan R; Zhou J; Zhong J
Int J Clin Exp Pathol; 2014; 7(12):8952-7. PubMed ID: 25674271
[TBL] [Abstract][Full Text] [Related]
6. IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.
Visperas A; Do JS; Bulek K; Li X; Min B
Mucosal Immunol; 2014 May; 7(3):625-33. PubMed ID: 24129161
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses.
McLean MH; Andrews C; Hanson ML; Baseler WA; Anver MR; Senkevitch E; Staniszewska AK; Smith C; Davies LC; Hixon J; Li W; Shen W; Steidler L; Durum SK
Inflamm Bowel Dis; 2017 Nov; 23(11):1983-1995. PubMed ID: 29019857
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.
Hanson ML; Hixon JA; Li W; Felber BK; Anver MR; Stewart CA; Janelsins BM; Datta SK; Shen W; McLean MH; Durum SK
Gastroenterology; 2014 Jan; 146(1):210-221.e13. PubMed ID: 24120477
[TBL] [Abstract][Full Text] [Related]
9. An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases.
Xu WD; Wang DC; Zhao M; Huang AF
Front Immunol; 2024; 15():1366377. PubMed ID: 38566992
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Environmental Factors in Autoimmune Thyroid Disease: Exploring Associations with Selenium Levels and Novel Loci in a Latvian Cohort.
Upmale-Engela S; Vaivode I; Peculis R; Litvina H; Zake T; Skesters A; Gogins D; Rovite V; Konrade I
Curr Issues Mol Biol; 2024 Mar; 46(3):2553-2565. PubMed ID: 38534778
[TBL] [Abstract][Full Text] [Related]
11. IL-27 induces an IFN-like signature in murine macrophages which in turn modulate colonic epithelium.
Andrews C; McLean MH; Hixon JA; Pontejo SM; Starr T; Malo C; Cam M; Ridnour L; Hickman H; Steele-Mortimer O; Wink DA; Young HA; McVicar DW; Li W; Durum SK
Front Immunol; 2023; 14():1021824. PubMed ID: 37153622
[TBL] [Abstract][Full Text] [Related]
12. Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level.
Barac IS; Iancu M; Văcăraș V; Cozma A; Negrean V; Sâmpelean D; Mureșanu DF; Procopciuc LM
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011777
[TBL] [Abstract][Full Text] [Related]
13. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.
Giraldez MD; Carneros D; Garbers C; Rose-John S; Bustos M
Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):787-803. PubMed ID: 34211157
[TBL] [Abstract][Full Text] [Related]
14.
Hayes KS; Grencis RK
Parasitology; 2021 Jun; 148(14):1-9. PubMed ID: 34078488
[TBL] [Abstract][Full Text] [Related]
15. IL-30
Min B; Kim D; Feige MJ
Exp Mol Med; 2021 May; 53(5):823-834. PubMed ID: 34045653
[TBL] [Abstract][Full Text] [Related]
16. Relationship of
He C; Liu J
Int J Clin Exp Pathol; 2018; 11(8):4147-4152. PubMed ID: 31949807
[TBL] [Abstract][Full Text] [Related]
17. The Immunobiology of the Interleukin-12 Family: Room for Discovery.
Tait Wojno ED; Hunter CA; Stumhofer JS
Immunity; 2019 Apr; 50(4):851-870. PubMed ID: 30995503
[TBL] [Abstract][Full Text] [Related]
18. Association of single-nucleotide polymorphisms in the IL27 gene with autoimmune thyroid diseases.
He W; Wang B; Mu K; Zhang J; Yang Y; Yao W; Li S; Zhang JA
Endocr Connect; 2019 Mar; 8(3):173-181. PubMed ID: 30694795
[TBL] [Abstract][Full Text] [Related]
19. Tipping the balance: inhibitory checkpoints in intestinal homeostasis.
Joosse ME; Nederlof I; Walker LSK; Samsom JN
Mucosal Immunol; 2019 Jan; 12(1):21-35. PubMed ID: 30498201
[TBL] [Abstract][Full Text] [Related]
20. The interleukin-27 -964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis.
He J; Zhang Q; Zhang W; Chen F; Zhao T; Lin Y; Li J; Liu Y; Liu Y; Shao Y
Crit Care; 2018 Sep; 22(1):248. PubMed ID: 30268141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
